MAST THERAPEUTICS, INC. Financials
moreView todays social media effects on MSTXView the latest stocks trending across Twitter. Click to view dashboardSee who Mast is hiring next, click here to view […]
MSTX
MAST THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
moreView todays social media effects on MSTXView the latest stocks trending across Twitter. Click to view dashboardSee who Mast is hiring next, click here to view […]
MAST THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
moreView todays social media effects on MSTXView the latest stocks trending across Twitter. Click to view dashboardSee who Mast is hiring next, click here to view […]
Mast Therapeutics Reports First Quarter 2014 Financial Results
[PR Newswire] – SAN DIEGO, May 5, 2014 /PRNewswire/ — Mast Therapeutics, Inc. (NYSE MKT: MSTX) today reported financial results for the quarter ended March 31, 2014. During the period, the Company made progress across … moreView todays social media effects on MSTXView the latest stocks trending across Twitter. Click to view dashboardSee who Mast is hiring next, click here […]
Vista Partners Publishes April 2014 Macroeconomic & Investment Newsletter
[Marketwired] – Vista Partners announced today that it published its FREE Macroeconomic & Investment Monthly Newsletter for the month of April. Each monthly newsletter from Vista contains macroeconomic thoughts from Principal … moreView todays social media effects on MSTXView the latest stocks trending across Twitter. Click to view dashboardSee who Mast is hiring next, click here to view […]
MAST THERAPEUTICS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities
moreView todays social media effects on MSTXView the latest stocks trending across Twitter. Click to view dashboardSee who Mast is hiring next, click here to view […]
Vista Partners Updates Coverage on Mast Therapeutics, Inc. (NYSE MKT: MSTX); Price Target $2.25
[Marketwired] – Vista Partners announced today that it has updated coverage on Mast Therapeutics Inc. , a publicly traded biopharmaceutical company headquartered in San Diego, CA; and maintains its twelve-month price … moreView todays social media effects on MSTXView the latest stocks trending across Twitter. Click to view dashboardSee who Mast is hiring next, click here to view […]
Mast Therapeutics Completes Acquisition Of Aires Pharmaceuticals, Inc.
[PR Newswire] – With MST-188 in an ongoing pivotal trial for sickle cell disease and a phase 2 trial expected to initiate this quarter in acute limb ischemia, the addition of another phase 2-ready asset further enhances our pipeline, providing us with di moreView todays social media effects on MSTXView the latest stocks trending across Twitter. Click to view dashboardSee […]
Mast Therapeutics Completes Acquisition Of Aires Pharmaceuticals, Inc.
[PR Newswire] – With MST-188 in an ongoing pivotal trial for sickle cell disease and a phase 2 trial expected to initiate this quarter in acute limb ischemia, the addition of another phase 2-ready asset further enhances our pipeline, providing us with di moreView todays social media effects on MSTXView the latest stocks trending across Twitter. Click to view dashboardSee […]
Mast Therapeutics To Present At The Cowen & Co. 34th Annual Healthcare Conference On March 3rd
[PR Newswire] – (NYSE MKT: MSTX) today announced that the Company’s Chief Executive Officer, Brian M. Culley, will present at the Cowen & Co. 34th Annual Healthcare Conference on Monday, March 3, 2014 at 4:50 p.m. Eastern time at The Boston Marriott Copl moreView todays social media effects on MSTXView the latest stocks trending across Twitter. Click to view dashboardSee […]
